Asian Journal of Andrology

| | | | | | | |

Search

Journal

－Ahead of print
－Authors' Accepted
Manuscripts new!
－Current Issue
－Archive
－Acknowledgments
－Special Issues
－Browse by Category

Manuscript Submission

－Online Submission
－Online Review
－Instruction for Authors
－Instruction for Reviewers
－English Corner new!

About AJA

－About AJA
－Editorial Board
－Contact Us
－News

Resources & Services

－Advertisement
－Subscription
－Email alert
－Proceedings
－Reprints

Download area

－Copyright licence
－EndNote style file
－Manuscript word template
－Guidance for AJA figures
    preparation (in English)
－Guidance for AJA figures
    preparation (in Chinese)
－Proof-reading for the
    authors
－AJA Club (in English)
－AJA Club (in Chinese)

Abstract

Volume 14, Issue 5 (September 2012) 14, 795–737; 10.1038/aja.2012.53

Re: 'Use of androgen deprivation therapy in prostate cancer: indications and prevalence' by Connolly et al

Bo-Eric Persson

Ferring Pharmaceuticals, St-Prex 1162, Switzerland

Correspondence: Dr BE Persson, (Bo-Eric.Persson@ferring.com)

published online 20 August 2012

Abstract

No abstract available

Browse: 2898

Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X　　Copyright © 2023　　Shanghai Materia Medica, Chinese Academy of Sciences.　　All rights reserved.